Cite
MLA Citation
T. Luft et al.. “Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl.” Leukemia research, vol. 55, n.d., pp. S120–S121. http://access.bl.uk/ark:/81055/vdc_100045920509.0x00000f
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
T. Luft et al.. “Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl.” Leukemia research, vol. 55, n.d., pp. S120–S121. http://access.bl.uk/ark:/81055/vdc_100045920509.0x00000f